Study to Assess the Effect of Co-administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran etexilate in Healthy Postmenopausal Female Volunteers

Trial Identifier: D8532C00004
Sponsor: AstraZeneca
NCTID:: NCT05438303
Start Date: June 2022
Primary Completion Date: December 2022
Study Completion Date: December 2022
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, CA Long Beach, CA, US, 90806
US, NJ Berlin, NJ, US, 08009